Tech Company Inital Public Offerings
Ikena Oncology IPO
Ikena Oncology was bought by . Ikena Oncology shares started trading on 3/26/2021.
Transaction Overview
Company Name
Announced On
3/26/2021
Transaction Type
IPO
Amount
$124,800,000
Proceeds Purpose
Use of proceeds for the Ikena Oncology IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
50 Northern Ave. 7th Floor
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Website
Email Address
Overview
Ikena envisions a world where every cancer patient has a cure. Ikena, headquartered in the biotech hub of Boston, Massachusetts, is dedicated to bringing next generation targeted oncology and immunometabolism therapies to patients suffering from cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Manfredi
Chief Financial Officer
Douglas Carlson
Chief Medical Officer
Sergio Santillana
Chief Scientific Officer
Jeffrey Ecsedy
Vice President
Alfredo Castro
Vice President
Alexander Constan
Vice President
Karen McGovern
VP - Bus. Development
Maude Tessier
VP - Manufacturing
James Nolan
VP - R & D
Michelle Zhang
Browse more venture capital transactions:
Prev: 3/26/2021: ABL Space Systems venture capital transaction
Next: 3/26/2021: Infinite Looks venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs